Effects of halofuginone on fibrosis formation secondary to experimentally induced subglottic trauma

被引：13

作者：

Ertugrul, E. Eylem ^{[1
]}

Cincik, Hakan ^{[1
]}

Dogru, Salim ^{[1
]}

Cekin, Engin ^{[1
]}

Berber, Ufuk ^{[1
]}

Gungor, Atila ^{[1
]}

Poyrazoglu, I. Ethem ^{[1
]}

机构：

[1] GATA Haydarpasa Educ Hosp, KBB Serv, ENT Dept, TR-34668 Istanbul, Turkey

来源：

LARYNGOSCOPE | 2007年 / 117卷 / 02期

关键词：

halofuginone; subglottic injury; stenosis; fibrosis;

D O I：

10.1097/01.mlg.0000250593.19282.47

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Objective: The aim of the study was to assess the antifibrotic effect of systemically applied halofuginone after subglottic injury. Materials and Methods. After standardized trauma to subglottic area, rats were divided into two groups: a study group that received treatment and a control group that did not. The rats were treated with 0.1 mg/kg/day intraperitoneal halofuginone injection for 30 days. The larynx specimens were examined histopathologically under light microscope for epithelization, inflammation, necrosis, and fibrosis. Results. The fibrosis indexes of the treated group were significantly less than those of the control group (P <.01). Conclusions: Systemically applied halofuginone hydrobromide decreases fibrosis/scar tissue formation secondary to experimentally induced acute subglottic trauma.

引用

页码：299 / 302

页数：4

共 15 条

[1] ACQUIRED SUBGLOTTIC STENOSIS IN CHILDREN [J].

CATLIN, FI ;

SMITH, RJH .

ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1987, 96 (05) :488-492

[2] The effects of mitomycin C and 5-fluorouracil/triamcinolone on fibrosis/scar tissue formation secondary to subglottic trauma (experimental study) [J].

Cincik, H ;

Gungor, A ;

Cakmak, A ;

Omeroglu, A ;

Poyrazoglu, E ;

Yidirim, S ;

Cekin, E ;

Candan, H .

AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2005, 26 (01) :45-50

[3] Can topical mitomycin prevent laryngotracheal stenosis? [J].

Eliashar, R ;

Eliachar, I ;

Esclamado, R ;

Gramlich, T ;

Strome, M .

LARYNGOSCOPE, 1999, 109 (10) :1594-1600

[4] Halofuginone prevents subglottic stenosis in a canine model [J].

Eliashar, Ron ;

Ochana, Meir ;

Maly, Bella ;

Pines, Mark ;

Sichel, Jean-Yves ;

Nagler, Arnon .

ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 2006, 115 (05) :382-386

[5] The effectiveness of hyperbaric oxygen treatment in tracheal reconstruction with auricular cartilage grafts (experimental study) [J].

Gungor, A ;

Poyrazoglu, E ;

Cincik, H ;

Sali, M ;

Candan, H .

AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2003, 24 (06) :390-394

[6] PATHOGENESIS OF SUBGLOTTIC STENOSIS FROM ENDOTRACHEAL INTUBATION [J].

HAWKINS, DB .

ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1987, 96 (01) :116-117

[7] The use of halofuginone in limiting urethral stricture formation and recurrence: An experimental study in rabbits [J].

Jaidane, M ;

Ali-El-Dein, B ;

Ounaies, A ;

Hafez, AT ;

Mohsen, T ;

Bazeed, M .

JOURNAL OF UROLOGY, 2003, 170 (05) :2049-2052

[8] Reduction in pulmonary fibrosis in vivo by halofuginone [J].

Nagler, A ;

Firman, N ;

Feferman, R ;

Cotev, S ;

Pines, M ;

Shoshan, S .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 154 (04) :1082-1086

[9] Halofuginone - An inhibitor of collagen type I synthesis - Prevents postoperative formation of abdominal adhesions [J].

Nagler, A ;

Rivkind, AI ;

Raphael, J ;

Levi-Schaffer, F ;

Genina, O ;

Lavelin, I ;

Pines, M .

ANNALS OF SURGERY, 1998, 227 (04) :575-582

[10] Topically applied Halofuginone, an inhibitor of collagen type I transcription, reduces peritendinous fibrous adhesions following surgery [J].

Nyska, M ;

Nyska, A ;

Rivlin, E ;

Porat, S ;

Pines, M ;

Shoshan, S ;

Nagler, A .

CONNECTIVE TISSUE RESEARCH, 1996, 34 (02) :97-103

← 1 2 →